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A brief overview of the effects of age on T cell function 
is presented. Normal immune functions can begin to 
decline shortly after an individual reaches sexual matu-
rity. Foremost among the cellular changes are those in 
the stem cells as reflected in their growth properties and 
the availability of precursor T cells, and in the T cells, in 
which a shift in subpopulations may be occurring. Pres-
ent evidence indicates that thymic involution precedes, 
and therefore may be responsible for, the age-dependent 
decline in the ability of the immune system to generate 
functional T cells. It now appears that the primary effect 
of thymic involution is on a T cell differentiation path-
way; the more mature T cells are affected first, the less 
mature T cells only later. Thus, the thymus may be the 
aging clock for the immune system. Current studies are 
centered on processes regulating growth and atrophy of 
the thymus, and methods for restoring the impaired 
immune function of elderly individuals. 
Aging is chamcterized by a declining a bility of the individual 
to adapt to envi.ronmental stress. This decline is exemplified 
physiologically by an inability to maintain homeostasis. There-
fore, many physiological systems are being experimentally scru-
tinized as a part of the search for the mechanism or mechanisms 
responsible for the deregulation of homeostasis and for methods 
to control diseases. Of these, the immune system is perhaps the 
most productive system, for the following reasons: 
A. Certain immune functions tend to normally decline with 
age in humans [1], guinea pigs [2], hamsters [3], rats [4], mice 
[5], dogs [6], and rabbits [7], a lthough the onset, magnitude, 
and rate of decline vary with the type of immune function and 
the species. 
B. The immune system is "organismal" in that it is in con-
tinual contract with most, if not all, cell, tissue, and organ 
systems within the body. Thus, a ny alteration in the immune 
system would be expected to affect all other systems. If one 
views aging as a pertUl'bation of homeostasis, a mobile, dynamic 
system such as the immune system is perhaps the ideal one in 
which to study such perturbations and their consequences. 
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C. As immunologic vigor decrea es, the incidence of infec-
tions, autoimmune and immune-complex diseases, a nd cancel' 
increases [8-12], e.g., in immunodeficient newborns and im-
munosuppressed adults [13-15]. A strong piece of evidence 
linking decreased immunologic vigor to disease is that one can 
prevent, or even reverse, the occurrence of immunodeficiency, 
wasting disease, amyloidosis, and autoimmunity in neonatally 
thymectomized and genetically susceptible mice by reconstitut-
ing them with young but not old, syngeneic thymus or spleen 
grafts [16,17]. Decreased T cell responsiveness and immune-
complex deposition have also been implicated as causative 
factors in arteriosclerosis [18]. 
D. The immune system is amenable to both cellular and 
molecular analysis. Therefore, it offers many opportunities for 
experimental manipulation. 
E. Delay, reversal, or prevention of the decline in normal 
immune functions may delay the onset or lessen the severity of 
diseases associated with aging. 
Present evidence suggests that the decline in immune func-
tions that accompanies aging is due primarily to changes in the 
T cell component of th e immune system, and that B cell 
changes are minimal or secondary to those of the T cells [19]. 
In this presentation, therefore, I will present an overview of the 
rapidly developing area of the aging of the immune system by 
first discussing the age-related cha nges in T cell activities, and 
then by focusing on the possible mechanisms that may be 
responsible for these changes. Before doing 0, I will briefly 
review the major components of the immune system . 
THE IMMUNE SYSTEM 
The immune system protects the body in a highly specific 
manner against foreign invasion by viruses, bacteria, fungi , and 
possibly one's own somatic cells that undergo neoplastic 
changes by seeking out and destroying them. Any factor or 
event that can decrease the normal policing activity of the 
immune system can promote the growth of invasive a ntigens 
(e.g., bacteria and cancer cells), which can, in turn, disrupt 
various physiological functions. Hence, it should be apparent 
that the immune system plays a major role in the preservation 
of health and, therefore, in life sustenance. 
The immune system is organismal, i.e., its cells are distributed 
throughout the body and circulate within the blood and lymph. 
The major lymphoid tissues are the thymus, lymph nodes, 
spleen, and bone marrow (Fig 1). The stem cells, found primar-
ily in the bone marrow, can differentiate into T cells, B cells, or 
macrophages. Macrophages and B cells are generated in the 
bone marrow, but T cells originate from pre-T cells under the 
influence of the thymus. 
Obviously, anything that affects the stem cells will affect the 
other components of the immune system. Unlike stem cells 
undergoing passage in vivo [21-23], whose self-replicating abil-
ity can be exhausted, stem cells in situ can self-replicate 
throughout the natw-allife span of an individual. However, the 
ability of stem cells to expand clonally and their rate of division 
decrease with age [24-26], as do their ability to repair x-ray-
induced DNA damage [27] and their ability to home into the 
thymus [28,29]. When investigators tried to reverse these age-
related kinetic parameters by enabling "old" stem cells to self-
replicate in syngeneic young recipients for a n extended period, 
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F Ie 1. Cellular traffic of the immune system. Reprinted from Mak-
inodan, T., Immunity and Aging, Handbook of the Biology of Aging, 
ediLed by J. E. Birren, Van Nostrand Reinhold Co., New York [20]. 
t hey found that the cells still behaved as old stem cells kineti-
cally. However, when "young" stem cells were allowed to self-
replicate in syngeneic old recipients, they behaved as old stem 
cells kinetically. These resul ts indicate that t he milieu of stem 
cells induces subtle but stable irreversible changes that affect 
their responsiveness to differentiation homeostatic factors. 
T cells are responsible for pro tecting the body against viruses, 
fungi, and certain types of bacteria; for preventing the growth 
of certain neoplasms; and for regulating B cell antibody pro-
duction to a large number of antigens. Human T cells are 
identified morphologically by their abili ty to form rosettes with 
sheep erythrocytes, and mouse T cells by the presence of the 
theta a ntigen on their surfaces. Assays for T cell activity include 
responsiveness to plant mitogenic lectins such as phytohemag-
glutinin (PHA), concanavalin A (Con A), participation in de-
layed hypersensitivity (i.e., skin- test) reactions, abili ty to mount 
graft-versus-host (GVH) reactions, and ability to help or sup-
press the responses of other cells. 
B cells can be identified by t he presence of immunoglobulin 
on their surface. The immunoglobulin can be detected by 
electron microscopy, or more commonly by immunofluorescent 
staining (Fig 2) . Generally, B cells cannot produce antibody 
without the direction of T cells, unless the a ntigens consist of 
repetitive subuni ts such as t hose found in most carbohydrates 
or polysaccharides. Assays for B cell activity include respon-
siveness to certa in mitogens such as lipopolysaccharide (LPS), 
antibody production in response to T-cell-independent and 
-dependent antigens, and colony-forming abili ty. 
Macrophages also participate in the immune response. They 
are derived from peripheral blood monocytes, which are derived 
from a bone marrow precursor cell [31). Macrophages cooperate 
with T and B cells in many immune responses; t hey phagocytize 
bacteria, some viruses, and senescent a nd damaged cells. Be-
cause macrophages usua lly confront antigens before t he T and 
B cells participate in most immunologic activit ies, many of the 
earlier studies on t he mechanism of loss in immunologic vigor 
with age were focused on macrophages. These studies showed 
that macrophages are not adversely affected by aging in t heir 
handling of antigens during both induction of immune responses 
and phagocytosis [32-35). 
AGE-RELATED CHAN GES IN T CELL FUNCTION 
A. Morphology 
The first hin t that normal T cell functions might decline with 
age came from the findings of morphologists who showed that 
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the thymic lymphatic mass decreased with age, primarily as a 
result of atrophy of the cortex. The onset of this decrease 
coincided with the attainment of sexual matmity, and was 
found in both laboratory animals and huma ns [36,37). Subse-
quently, atrophy of the epithelial cells and decreased levels of 
thymus hormone or hormones have been observed. Histologi-
cally, the cortex of an involuted thymus is sparsely populated 
with lymphocytes that are replaced by numerous macrophages . 
filled with lipoid granules [38). In addition, infiltration of plasma 
and mast cells can be observed in the medulla as well as in the 
cortex [38). Although the size of lymph nodes and spleen 
remains about the same after adulthood in individuals without 
lymphatic neoplasia [36,37], the cellular composit ion of these 
tissues shifts so that there are diminished numbers of germinal 
centers and increased numbers of plasma cells and macro-
phages, as well as increased a mounts of connective tissue [39, 
40). In humans, t he number of circulating T cells has been 
reported to decrease progressively after adulthood to a level 
that is 70% that of a young adult by the 6th decade of life, or to 
remain the same [41-43). Autologous erythrocyte binding, pre-
sumably to immatme T cells, increases with age [44). 
B. Cellular Changes 
In vivo changes: In general, T-cell-dependent cell-mediated 
functions decline with age. However, there are conflicting re-
ports in the Iiteratme concerning certain functions in aging 
humans and animals [2,9,45-48]. For example, some investiga-
tors have reported a decrease in delayed skin hypersensitivity 
to common test antigens to which individuals had been previ-
ously sensitized (such as purified protein derivative of tuber-
culosis, streptokinase-streptodornase, Candida, Trichophyton, 
etc.). Others have reported no decrease except in elderly persons 
with acute illness. One may argue that any decrease in delayed 
hypersensitivi ty seen in the elderly reflects aging of the skin 
rather tha n the immune system. However, results of tumor cell 
rejection tests in aging mice were comparable, and because 
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FIG 2. Human B cell with flu oroscein-Iabeled antihuman immuno-
globulin bound to the immunoglobulins on its surface. When exposed 
to ultraviolet light, the flu orescein-labeled molecules fluoresce a bright 
green. The B cell that posed for this picture has immunoglobulin 
(represenLed by "Y") on its surface to which fluoroscein-labeled antiim-
munoglobulin antibodies (represented by "Y") have become bound 
[taken from reference 30]. 
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t umor cells were injected intraperitoneally in these tests, aging 
of the skin was not the limiting factor [46). It is more likely 
that the conflicting results are attribu table (a) to utilization of 
only 1 skin test antigen to assess T cell function, (b) to selection 
of skin test antigens (e.g., because only a fraction of the U. S. 
population has been immunized aginst tuberculosis, a negative 
result cannot be interpreted as refl ective of defective immuno-
. logic memory) , and (c) to selection of the population samples 
(i.e., some studies have used hospitalized patients and medical 
clinic populations). Bel:ause of these considerations, it is rec-
ommended that a battery of common test a nt igens be utilized 
for the assessment of secondary delayed skin hypersensit ivity 
reactions. 
In contrast to its controvers ial role in secondary delayed skin 
reactions, T cell function in primary delayed skin reactions in 
response to antigens to which the individuals have not been 
sensitized previously, such as dinitrochlorobenzene (DNCB), 
declines with age. 
Studies performed in vivo with mice indicate that various T-
cell-dependent functions decline with age [46,49-51)' Thus, cells 
from old mice have a decreased a bility to mount a G VH reaction 
[49,52], even when enriched T cell populations are utilized to 
compensate for t he possibility that old animals may have fewer 
T cells [52). Resistance to challenge with syngeneic and allo-
geneic tumor cells in vivo decreases dramatically with age 
[49,53). It is of significance that, in t he studies mentioned above, 
the decline in response to PHA measured in vitro approximated 
t he decline in GVH reaction and tumor cell challenge measured 
in vivo [49). 
In vitro changes: The findings from experiments performed 
in vitro show that the proliferative capacity of T cells of human 
beings and rodents, in response to PHA, Con A, and allogeneic 
target cells, declines wi t h age [1,3,49,54-63]. The PHA-stimu-
lated lymphocytes from aged individuals bind less tritiated 
actinomycin than those from younger individuals [64,65). 
The decline in the cell-mediated lymphocytotoxicity (CML) 
index of T cells of long-lived mice has been reported to be 
moderate against allogeneic tumor cells and not readily appar-
ent against certain syngeneic tumor cells [46). The discrepancy 
between results of tumor cytotoxicity tests performed in vivo 
and in vitro may be due in part to inadequate culture conditions 
in the latter, as indicated by the demonstration that a significant 
decline with age in the mixed lymphocyte cul ture (MLC) re-
action can be detected with improved culture methods [66). 
There has been a s ingle report that the response to PHA in 
mice shows only a minimal decline with age [67). However , in 
this report, "middle-aged" rather than old C57B1/6J mice were 
used; 15- to 20-mo-old mice were used when the mean life span 
(MLS) of the mice in that laboratory was 24 mo, a procedure 
equivalent to assaying 44- to 58-YJ'-old humans whose MLS is 
70 yr. This fact directs attention to an important point: the age 
at which a mouse is "old" varies with the strain. For example, 
in 1 laboratory the MLS of DBA/2 males is 86 weeks whereas 
the MLS ofC67B1/6J males is 130 weeks [62,68). FUlthermore, 
the MLS of a strain can vary between laboratories because the 
animal housing conditions can vary; e.g. , C57Bl/6J that have 
an MLS of 120 weeks in some laboratories may have an MLS 
of 97 weeks in others [69,70). Thus, a 90-week-old C57B1/6J 
mouse could be considered "old" in 1 laboratory but "middle-
aged" in another. 
It should be emphasized that young adult mice (3 to 10 mo 
old) rather than "young" mice (:S 2 months old) should be used 
as a reference point for aging studies. The latter may be 
"immat ure" immunologically, according to the immunologic 
index. For example, it was shown in 1 laboratory that the 
antisheep erythrocyte response of BC3F, mice (MLS, 30 mol 
does not mature until 6 mo of age [5], but their response to 
PHA peaks a t 8 mo of age [58). A further complication encoun-
tered with immature young mice is that variability between 
individuals is greater than in young adults. The description of 
mice as "old" or "young," then, should be based upon the 
survival and developmental pattern of each individual strain. 
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This practice would reduce the number of conflicting reports 
regarding t he effects of age on immune functions. 
There are conflicting reports in the literature on the effects 
of age on the MLC reaction. Some investigators have reported 
a marked decrease with age [54,58,71,72). Others have reported 
that cells from old mice are equally, if not more, efficient than 
cells from young mice, as both responding and stimulat ing cells 
in the MLC reaction. However, t he same cells showed a de-
l:reased GVH reaction index [52). Some of these discrepancies 
would be avoided if investigators would not use mitomycin-
treated cells as the stimulating cells in t he MLC reaction. 
Mitomycin may leak from the stimulating cells, and responding 
cells from old a nimals may be more susceptible to t his drug 
than cells from young anin1als. A more sound approach to the 
ut ilization of the MLC index, when studying the effects of age 
on cell-mediated immunity, is the use of either x-rayed or 
hybrid cells from donors of 1 age group as the stimulating cells. 
MECHANISMS OF THE AGE-RELATED DECLINE IN 
NORMAL IMMUNE FUNCTIONS 
One of the hallmarks of immunosenescence is the increase in 
variability of immune indices [60,73). If more than 1 factor were 
responsible for the increase in variability, it would not be 
surprising to find that the decline in immune capacity of aging 
mice resulted from changes in the immune cells, changes in 
their milieu, or both. To differentiate between the influences of 
cells a nd theil" milieu, investigators used the cell transfer 
method, which assesses immunocompetent cells from you ng 
a nd old mice in immunologically inert old and young syngeneic 
recipients, respectively [46,74-76). The results revealed t hat 
both types of change affect the immune response, that about 
10% of the normal age-related decline can be attributed to 
changes in the cellular milieu, and that 90% of the decline can 
be attributed to changes intrinsic to the old cells [75,76). 
A. Cellular Milieu 
The responsible factor (or factors) in the cellular envil"onment 
was shown to be systemic and noncellular [75,76). Spleen cells 
from young mice were cultmed with the test ant igen either in 
the young (or old) r ecipient's spleen by the cell transfer method, 
or in the recipient's peritoneal cavity by t he diffusion chamber 
method [77). A 2-fold difference in response was observed 
between young and old recipients at both sites, an indication 
that the factor is systemic. The fact that the effect was observed 
in cells g1'own in cell-impermeable diffusion chambers further 
indicates that a noncellular factor is involved. A comparable 2-
fold difference was also observed when bone marrow stem cells 
were assessed in the spleens of young and old syngeneic recip-
ients [27J, an indication that the systemic, noncellular factor 
influences both lympho- and hematopoietic processes. 
The factor could be a deleterious substance of molecular or 
viral nature, or ' it could be an essential substance that is 
deficient in old mice. Factors of both types probably change 
with age, and fmthermore, several factors of each typ e may 
exist. 
Unfortunately, this area of research has not progressed as 
rapidly as anticipated because a simple, sensitive in vitro assay 
to analyze mouse serum has not yet been perfected. For exam-
ple, it is unclear why normal adult mouse serum, but not fetal 
bovine serum, is toxic for mouse immunocompet~nt cells g1"own 
in vitro. 
B . Cellular Changes 
Ttu"ee types of cellular changes could cause a decline in 
normal immune functions: (a) an absolute decrease in cell 
number t tu"ough death, possibly caused by autoimmune cells, 
(b) a relative decrease in cell number as a result of an increase 
in the number of "suppressor" cells, and (c) a decrease in 
functional efficiency caused, perhaps, by somatic mutat ion. One 
approach to resolving this problem is t o first estimate the 
frequency of old mice that exhibit these cellular changes. This 
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estimation can be accomplished through t he assessm ent of the 
activity of reference immune cells from adult individuals in the 
presence of immune cells from old individuals. A response of 
young-old cell mixtUJ"es that was less than the sum of t he 
responses given by pure young and pure old cells would indicate 
that t he decreased response of old individuals was due to an 
increase in suppressor cells. If the responses of the mixtures 
were comparable, it would indicate t hat the decreased response 
of old individuals was caused either by a decrease in theu' 
functiona l efficiency or a general loss of unmune cells. If the 
response of the young-old mixture was higher than the sum of 
responses given by pure young and pUTe old cells, it would 
indicate t hat t he decreased response of old individuals was 
caused by a selective loss of 1 type of immune cell that existed 
in excess in young individuals. The resul ts showed that all 3 
types of interactions can occur. This finding supports the con-
tention that although there may be only 1 underlying mecha-
nism respo nsible for the loss of immunologic vigor with age, it 
is expressed differently by aging individuals, a nd this difference 
contributes to the increased variability in immunologic per-
formance with age. 
Because involution of the thymus precedes the age-related 
decline in T cell function, a cause and effect relationship has 
been suspected (i .e., thymic involution results in a decreased 
capac ity of the system to generate functional T cells ). Experi-
ments have shown t hat adult t hymectomy accelerates the de-
cline in immune responsiveness by demonstrating a decreased 
hemaggluti nin response to sheep eryth.rocytes, particularly in 
the early response (19S) phase [78]; a marked decrease in the 
GVH reaction; th e poor general condition of the mice; and a 
reduced a ntibody response to bovine serum albumin [79). The 
effect on the latter response was less pronounced than that on 
t he GVH reaction. 
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Recently, HU'okawa and M akinodan [80] tra nsplanted thy-
mus lobes from mice 1 day to 33 mo of age into young adult, T-
cell-deprived recipients. They then kinetically assessed the 
emergence of T cells (Fig 3A, B) . The thymectomized, x-irra-
diated (and therefore T-cell-deficient) mice were given stem 
cells from bone marrow so that they could produce all blood 
cells. (Because they did not have thymuses, they could not 
produce T cells from the pre-T cells made by the bone m arrow.) 
Each thymus graft was placed in the capsule of a kidney to 
provide it with a good blood supply. In this situation, pre-T 
cells from the bone marrow of recipient mice migrated into the 
thymus grafts and were transformed in to T cells if the thymus 
had t he ability to induce the transformation. The recipient mice 
were examined (a) for repopulation of the paracortical (T-cell-
dependent ) areas of t he lymph nodes, (b) for the number of 
cells with t he theta (T cell) antigen on their sUJ"faces, (c) for 
theu' responses to the T cell mitogens PHA and succiny l-Con 
A, (d) for T-cell-dependent antibody responses to sheep eryth-
rocytes v ia a plaque assay, and (e) for mitogenic reactivity of 
splenic cells to allogeneic lymphocytes (MLC reaction). The 
thymic tissues lost the following influences: the influence on 
lymphocyte repopulation of T-cell-dependent areas of lymph 
nodes (compare step A in Fig 3A, B); the influence on mitogen 
responsiveness of splenic T cells to PHA and succinyl-Con A 
(see step B in Fig 3A, B) ; the influence on the number of spleen 
cells with the theta (T cell) a ntigen (refer to step B in Fig 3A, 
B) ; a nd the influence on the mitogenic reactivity of spleen cells 
to allogeneic lymphocytes. HU'okawa and Makinodan found (i) 
t hat the ability of the thymus t issue to influence the differen-
tiation or matUJ"ation of precursor cells into functional T cells 
decreased with increasing age a nd (ii) that the various T cell 
activities exhibited different susceptibilities to thymus involu-
tion [80). 
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PIG 3, The extent to which age-related involu tion of the thymus affects its capacity to transform pre-T cells in to T cells (see reference 80 for 
details) , Thymectomized mice were exposed to x- irradiation for destruction of any remaining T cells. They then were given stem cells from bone 
marrow so that they could produce all blood cells. These thymectomized, x-irradiated, bone-marrow-reconstituted (TXB) mice received 
transplants of thymuses from donor mice between 1 day and 33 mo of age. The TXB (recipient) mice were then examined for various responses, 
such as mitogenic reactivity of splenic cells to allogenic lymphocytes (mixed lymphocyte culture reaction) and responses to the T cell mitogens 
phytohemagglu tin in (PHA) and sllccinyl-concanavalin A (S,COIl,A). A, transplantation of thymuses from I-day-old donors. B, transplantation of 
thymuses from 33-mo-old donors. 
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FIG 4. Postulated effects of age on T cell differentiation. Present 
evidence suggests that thymic involution leads to a decrease in normal 
peripheral effector functions by altering the proportion ofT cell subsets. 
It seems that some T cell subsets, which are necessary for the initiation 
of certain immunologic activi ties, decrease wi th age. It has been hy-
pothesized that certain T cells, under the influence of a thymic hormone 
or hormones (shown here as the teacher, Thymic H), differentiate in to 
mature T cells (A) . With age, the level of the thymic hormone decreases. 
Thus, some T cell subsets do not become "educated" and are not 
effective in the process of life maintenance (B) [taken from reference 
30). 
In recent experiments performed in my laboratory with duo-
mosome markers and para biotic mice between 8 to 12 weeks of 
age, the movement of stem cells into the thymus seemed to 
cease [28). Thus, at least during this growth phase, it appears 
t hat the cells within the thymus are self-perpetuating. This 
may also be true of peripheral T cells. The cessation of stem 
cell traffic into the thymus prior to adolescence is probably due 
to changes in t he thymus since stem cells are capable of 
migrating into t hymic transplants, as demonstrated by Hiro-
kawa a nd Makinodan's study [80]. However, participation of an 
extrathymic regulatory m echanism cannot be excluded. It is 
significant that the cessation of stem cell to T cell traffic occms 
dming a growth phase of the individua l, and before detectable 
thymic involu tion or a decrease in t he number of T cells in the 
thymus, lymph nodes, or spleen [28). 
In this regard, terminal deoxynucleotidyl transferase (TdT), 
peak II, decreases in the thymuses of long-lived mice from 4 mo 
of age onward [81). The TdT catalyzes the polymerization of 
deoxynucleotides in the presence of a primer, in vitro. However , 
the function of this enzyme in vivo is not known. It has been 
postulated that it may be a somatic mutagen for immunologic 
diversification [82). 
These observations indicate that thymic involution precedes, 
and is responsible for, the age-dependent decline in the ability 
of the immune system to generate functional T cells. But what 
is the mechanism by which thymic involution leads to a de-
crease in normal peripheral effector cell functions? It appears 
that involution of t he thymus alters t he proportion of T cells, 
possibly through decreased synthesis of differentiation hor-
mones, through synthesis of factors that can alter cells (Fig 4), 
or through both mechanisms. The observations listed below 
support this view. 
1. The proportion of mouse lymphocytes bearing the theta 
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antigen decreases with age, as does the amount of theta a ntigen 
on cell surfaces; yet there is no compensatory increase in B 
lymphocytes, nor does the lymphocyte number change signifi-
cantly (Fig 5) . These facts suggest an increase in T cells that do 
not carry detectable theta receptors on t heir surfaces [83). 
2. Although PHA-induced blastogenesis of cells from old 
mice is significantly reduced (Fig 4), t hese cells bind 1 ~r, I-labe led 
PHA just as well as cells from young mice [84). Because there 
seems to be no significant decrease in binding affiniti es or 
r eceptor sites for PHA on cells of old mice, the defect cannot be 
in their membrane receptors. 
3. The cycl ic nucleotide 3',5'-guanosine monophosphate, 
which has been shown to increase when T cells are stimulated 
by mitogens, is found in rela tively small concentrations in 
mitogen-stimulated T cells of old mice (Fig 6). The levels of 
cyclic nucleotides are hormone-dependent [85,86], an indication 
t hat the defect in T cells is intracellular and may be hormone-
dependent . 
4. The life span of hypopituitary dwarf mice, which are T-
cell-deficient, can be extended from 4 mo to 12 mo by a single 
intraperitoneal injection of 150 X 10(; lymph node cells rich in 
A. B. 
tsbskor-; m:J. 
FIG 5. T cell aging. This figure shows a T cell aging before your 
eyes. A, a T cell that has decreased amounts of theta or T cell antigen 
on its surface. B, a T cell that loses theta as it ages [taken from 
reference 30l 
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FIG 6. Effect of age and chemicals on cyclic nucleotide levels of 
phytohemagglutinin-stimulated (PHA-stimulated) T cells. A, when T 
cells from young individuals are stimulated with PHA, the level of t he 
cycl ic nucleotide 3',5'-guanosine monophosphate (shown here as blach 
dots within the membrane) increases. B, when T cells from old individ-
uals are stimulated with PHA, the cyclic nucleotide level and the 
amount of cel.l pmliferat ion remain relative ly low. However, addition 
of 2-mercaploetha nol or po)ynuc!eotides to the cul ture significantly 
increases the blastogenic response of old cells to PHA [taken ii'om 
reference 30]. 
mature T cells, but a single injection of an equal number of 
ceLls 6'om a thymus deficient in mature T cells, or 50 X 10" bone 
marrow cell s, is ineffective (Fig 7 [17,87]) . Comparable life 
prolongation has been demonstrated by injection of growth 
factors a nd thyroxine in untreated, but not in thymectomized, 
dwarf mice [16,17]. This prolongation suggests that mature T 
cells are req uired for the approxjmation of homeostasis, bu t 
that their activities cannot be sustained throughout t he normal 
life span of t he species without replenishment from a precursor 
pool and, perhaps, a favorable hormonal environment. 
5. Transfer of 5 X 107 to 5 X 10~ t hymus cells from immu-
nologically mature congenic donors into athymic mice recon-
stitutes th e recipi ents' capacity to reject allogeneic skin grafts, 
whereas transfer of an equal number of thymus cells from 
newborn mice does not [88]. Presumably, the ability of thymus 
cell suspensions fTom adult mice to reconstitute graft rejections 
depends on the number of "competent" lymphocytes residing 
in the thymic medulla or those from the recU'cuJating pool that 
are trapped in the thymus cell suspensions. 
6. Cell-cycle experiments on the proliferative response of T 
cells to mitogens and alIoantigens demonstrate (a ) that T cells 
of young and old mice have the same generation time (i .e., "" 9 
hI') and (b) that the length of each stage of the cell cycle 
probably is the same for both young and old cells [89,90]. 
Because the age-related decline in t he proliferative responses 
cannot be attributed to an altered generation t ime or to a 
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reduced capacity for repeated cell division, the decline is prob-
ably due to a reduced number of responding cells. 
7. The absolute number of colony-forming, circulating hu-
man T cells decreases with age (55 to 82 yr) to a level that is 
< 17% that of adults 21 to 35 yr of age (Fig 8 [91]) , In addition, 
colony-forming T cells of older individuals exhibi t a delay in 
initiating division and decreased proliferative capacity [91]. 
These T cells exhibit morphological and histochemical charac-
teristics consistent with those of the subpopulation of T cells 
that show helper, rather than suppressor, activity, as described 
by others [92,93]. This evidence suggests that with age there is 
a shift in lymphocyte subpopulations that leads to a decrease 
in a responsive subset of T cells. 
8. DenSity distribution anaJysis, with bovine serum aJbumin 
and ficoll discontinuous gradients, shows that the frequency of 
less dense cells (p 1.06 to 1.08) increases at the expense of the 
more dense cells (p 1.10 to 1.12) [94]. This density shift within 
the lymphocyte population can also be seen in young mice 
shortly after they have been immunized with foreign erythro-
cytes or allogeneic lymphocytes, and in t umor-bearing mice. In 
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FI G 7. Effect of T cells on the life span of hypopi tui tary dwarf mice. 
Once upon a time in the la borato ry of Drs. Fabris, Pierpaoli , and 
Sorkin, there were hypopitui tary dwarf mice. Besides being dwarves 
(which was bad enough) , these poor beasts were a lso T-ceU-deficient. 
As a resu lt of the latter condition, they died at 4 mo of age. The good 
doctors wracked their brains trying to find a way to prolong the lives of 
their mice. They injected thymus or bone marrow cell suspensions, but 
these treatments were futile because the cell suspensions lacked mature 
T cells. In desperation, th e.Y injected I'ymph node cells containing 
mature T cells. Although the dwarf mice did not live happily ever after, 
they did live to be 12 mo old (i .e., 3 times lheil' normalliIe span) [taken 
from reference 30l 
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FIG 8. Effect of age on coLony-forming, circulating human T cells. 
Kinet ic studies have revealed that colonies fo rmed by T ceUs fi·om 
young individua ls achieve maximum number by 3 days postculture and 
that those from older individuals do not reach max imum number unt il 
6 days. Fewer colonies are formed by T ce lls fro m older individua ls. In 
addition, the size of the colonies produced by cells from older individuals 
is smaller than that produced by cells from young individua ls. 
t hese latter mice, however , the spleen cell number increases, 
whereas in unimmunized old mice it does not. This phenomenon 
s uggests that there is a relative increase with age in immatw·e 
T cells at the expense of mature T cells. 
9. S hortly after the thymus begins to involu te and atrophy, 
th e level of serum thymic hormone or hormones decreases with 
age [95]. It would seem reasonable to assume that this hormone 
is necessary for terminal differentiation of T cells, which could 
lead to a decrease in certain normal effector cell functions, to 
an increase in suppressor function, and thus to a deficit in 
overall T cell responsiveness (Fig 4) . 
10. The PHA response of T cells from old mice can be 
significantly increased in vitro by the addition of certain chem-
icals (e.g., mercaptoethanol and polynucleotides) to the cul-
t w-es, as can the antibody response to sheep erythrocytes (Fig 
6A, B [24,96,97]) . This effect supports the view that old mice 
are deficient in a hormone that is essential for t he differentiation 
of T cells to become responsive to a mi togen and also suggests 
t hat simple chemicals can be substituted for this hormone. 
How these regulatory T cells function as suppressors and 
h elpers is not known; therefore, studies on age-related changes 
in T cells involved in the regula tion of B cell immune responses 
have not been extensive. This dearth is due in part to the 
complexities of the system. The recent development of antisera 
directed against allelic T cell determinants (Ly differentiation 
antigens), which allows identification of 3 T cell subsets, should 
greatly facilitate research in the area of age effects on T cell 
suppressor function [98,99]. It seems that T cells expressing the 
Ly 1 antigen are responsible for helper and delayed hypersen-
sitivity effects and that cells expressing Ly 2,3 are responsible 
for suppressor effects and for cell-mediated cytolysis [98,99]. 
No specific function has yet been assigned to Ly 1,2,3 cells [for 
a complete review of suppressor cells in aging, see reference 
100]. 
The evidence that suppressor T cell activi ty declines with 
age was derived from studies on short-lived New Zealand black 
(NZB) and related mice [101]. ViTa l infections of the C type, 
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however, playa major role in t he genesis of the disease of NZB. 
The causes and mechanisms of t he decline in normal immune 
functions, and of immunodeficient diseases in these animal 
models, may be different from those in long-lived mice and 
elderly humans. We may be observing phenotypic cru:icatw-es 
of old-age immune deficiency that are analogous to the pheno-
typic featw-es of accelerated aging seen in progeric humans. 
Thus, although a decrease in suppressor T cell activity with age 
can account for the emergence of autoantibodies in older short-
lived mice, it cannot account for the emergence of autoantibod-
ies in older long-lived mice. In the latter mice the relative 
number of suppressor T cells increases slightly with age 
[75,76,102,103]. 
Increases in the number of regulator T cells with suppressor 
activity can interfere with the B cell response to antigenic 
stimulation by reducing eit her the number of antigen-respon-
sive immunocompetent uni ts or the magnitude of immunologic 
burst size. The notion that the number of regulator cells with 
inhibitory activities increases with age was ini t ially tested 
through assessment of the antisheep erythrocyte response of 
spleen cells from young mice in the presence and in the absence 
of spleen cells from old mice [27]. T he ratio of the observed 
response to that which would have been expected if t he re-
sponse of young and old cells had been addi tive was <1. These 
resul ts indicate that spleens of old mice contain regulator cells 
that can interfere with the immunologic activit ies of spleen cells 
from young mice. The proliferative response of T cells from 
young mice to PHA and allogeneic target cells was also assessed 
in a similar manner. These ini t ia l studies have been confirmed 
and extended with cells from both aging mice and humans 
[63,103,104]. 
The helper function of T cells declines with age. This fact 
has been demonstrated in intact animals as well as t hrough 
assays performed both in vivo and in vitro [35,75,76,101]. The 
ability of canier-primed T cell populations to collaborate with 
young mouse B cells primed with hapten (2,4-dinitrophenol) 
decreases dramatically with age [105]. 
Finally, T cells may also regulate hematopoiesis [106], for it 
has been shown that hematopoiesis of parental stem cells in 
heavily irradiated F 1 recipients can be augmented in the pres-
ence of parental T cells. 
c. Thymus 
All the relevant studies to date indicate t hat the process of 
involution and atrophy of the thymus is the key to the aging of 
the immune system. It fo llows, then, that the search for the 
causes and mechanisms of aging of the immune system should 
be oriented ru·ound the thymus. The causes may be either 
extrinsic or intrinsic to the thymus. The most likely extrinsic 
cause is a breakdown in the regulation of the thymus by the 
hypothalamic-pituitru-y new-oendocrine axis [16,17,107]. Intrin-
sic causes might be found at either t he DNA level or th e non-
DNA level [for moleculru· theories of aging, see reference 108]. 
It has been found that stress and other psychological factors 
can affect the immune response as measured by skin graft 
rejection, and by primary and secondru·y antibody responses. 
Lesions in the anterior basal hypothalamus, but not in the 
median or posterior hypothalamus, can depress delayed hyp er-
sensitivity and reduce the severity of anaphylactic reactions 
[for review, see reference 109]. Growth hormone and insulin 
have been shown to act preferentially on T-dependent in1mune 
functions. Thyroxine and sex hormones influence both T and B 
cell responses [for review, see references 16 and 17]. On the 
other hand, t here is evidence t hat the thymus can modulate 
hormone levels [16,17,110,111]. The area of thymic-neuroen-
docrine interactions should be an excit ing and fruitfu l subject 
for future aging reseru-ch . 
With respect to intrinsic causes, 3 possible mechanisms of 
involut ion and atrophy can be proposed. One is clonal exhaus-
t ion [112]; thymus ceUs might have a genetically programmed 
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clock mechanism to self-destruct and die after undergoing a 
fixed number of divisions. The mechanism would be similar to 
that of the Hayfli ck phenomenon, which is seen, in vitro, in 
human fibrob lasts. It would require eit her that the thymus 
count the cells leaving it or that the cells count the divisions 
t hey have undergone, or both. Another possible mechanism is 
an alteration in thymus cell DNA, either randomly or through 
viral infection [113]. Various stable alterations in DNA, includ-
ing cross-linking and breaks, can occur [for review, see referen ce 
114]. The 3rd possible mechanism is a stable molecular altera-
tion at the non-DNA level through subtle error-accumulating 
mecha nisms. 
At th e level of t he genes, evidence is mounting that genes of 
the H -2 system in mice a nd the HLA region in humans influence 
immune responsiveness and disease susceptibility [115-118]. 
CONCLUDING REMARKS 
An attempt has been made to summarize present knowledge 
and to show potential future progress in the areas of age-related 
changes in T cell immune function and mecha nisms of the age-
r ela ted decline. 
N ormal immune functions can begin to decline shortly after 
an individual reaches sexual maturity. Although changes in the 
environment of the cells are partially responsible, the decline is 
due primarily to changes in t he cells. Foremost among the 
cellular changes are those seen in the stem cells as reflected in 
their growth properties , and in T cells, where a shift in subsets 
may be occurring with age. It appears that the process or 
processes regulating involution a nd atrophy of the thymus 
could be the key to immunosenescence. Future studies on the 
mechanism or mechanisms responsible for decreased function 
are expected, therefore, to focus as much on the area of the 
neuroendocrine-thymic axis as they do on possible intrinsic 
mechanisms. The increasing size of the aged population is 
rapidly becoming one of the most critical socioeconomic issues 
on this planet. Innumerable diseases are associated with age 
and with the loss of immunologic vigor. The immune system is 
one of t he most attractive systems for attempting intervention 
in the debilitative processes associated with aging, for many 
reasons. It is a distinct, semiautonomous system and an organ-
ismal one that interacts with, protects, a nd affects all other 
systems. The age-related decline in immune functions precedes, 
and presumably causes a predisposition to, many of the diseases 
seen in e lderly individuals . The immune system is easily ap-
proached mechanistically and is amenable to restorative ma-
nipula tion. As understanding of the aging immune system in-
creases, I anticipate that methods will be developed to predict, 
minimize, delay, and prevent the debilitative processes associ-
ated with aging. 
I am grateful to J erry Sprou l for his excellent assis ta nce in preparing 
this manuscrip t and to Dr. Lynn Baker for drawing Figures 2-7. 
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